ACHILLES THERAPEUTICS PLC's ticker is ACHL and the CUSIP is 00449L102. A total of 30 filers reported holding ACHILLES THERAPEUTICS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $3,307,000 | -17.2% | 1,463,251 | -7.7% | 0.06% | -15.3% |
Q2 2022 | $3,994,000 | -14.3% | 1,584,845 | 0.0% | 0.07% | -5.3% |
Q1 2022 | $4,659,000 | -41.3% | 1,584,845 | 0.0% | 0.08% | -25.5% |
Q4 2021 | $7,940,000 | -35.7% | 1,584,845 | 0.0% | 0.10% | -25.0% |
Q3 2021 | $12,346,000 | -20.4% | 1,584,845 | 0.0% | 0.14% | -13.4% |
Q2 2021 | $15,516,000 | -40.8% | 1,584,845 | 0.0% | 0.16% | -35.9% |
Q1 2021 | $26,229,000 | – | 1,584,845 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Syncona Portfolio Ltd | 11,086,909 | $55,545,000 | 53.06% |
RA Capital Management | 5,014,687 | $25,124,000 | 0.44% |
Artal Group S.A. | 2,255,375 | $11,299,000 | 0.31% |
Redmile Group, LLC | 2,088,089 | $10,461,000 | 0.24% |
Orbimed Advisors | 1,584,845 | $7,940,000 | 0.10% |
Sender Co & Partners, Inc. | 27,690 | $139,000 | 0.07% |
Baker Brothers Advisors | 2,591,366 | $12,983,000 | 0.06% |
Perceptive Advisors | 1,510,750 | $7,568,000 | 0.06% |
Woodline Partners LP | 324,387 | $1,625,000 | 0.02% |
Point72 Asset Management, L.P. | 1,000,000 | $5,010,000 | 0.02% |